Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of Californ...
Nexalin Technology, Inc. (NXL)
Company Research
Source: Yahoo! Finance
The data supports the Company's strategy to offer military and civilian physicians a new tool to effectively treat mTBI without the use of medication, and without side effects or adverse events HOUSTON, TEXAS, March 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced the positive results of a clinical study evaluating Nexalin's Gen-2 tACS device for reducing pain in veteran patients with Mild Traumatic Brain Injury (mTBI). The study was conducted at The University of California, San Diego, and is further detailed in an abstract co-authored by the United States Department of Veterans Affairs (VA) San Diego Healthcare System, and the Radiology, Psychiatry and Neurosciences Departments of UC San Deigo. mTBI is a leading cause of sustained physical, cognitive, emotional, and behavioral deficits in veterans and the general public. However, the underlying pathophysiology is not completely understood, and there are few
Show less
Read more
Impact Snapshot
Event Time:
NXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NXL alerts
High impacting Nexalin Technology, Inc. news events
Weekly update
A roundup of the hottest topics
NXL
News
- Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on May 23 [Yahoo! Finance]Yahoo! Finance
- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on May 23GlobeNewswire
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements [Yahoo! Finance]Yahoo! Finance
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsGlobeNewswire
- Nexalin Technology CEO Provides Letter to Shareholders [Yahoo! Finance]Yahoo! Finance
NXL
Sec Filings
- 5/14/24 - Form RW
- 5/10/24 - Form 10-Q
- 4/26/24 - Form 8-K
- NXL's page on the SEC website